Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial.
Philis-Tsimikas A, Asong M, Franek E, Jia T, Rosenstock J, Stachlewska K, Watada H, Kellerer M.
Hypoglycemia in diabetes: The dark side of diabetes treatment. A patient-centered review.
Johnson-Rabbett B, Seaquist ER.
J Diabetes. 2019 Sep;11(9):711-718. doi: 10.1111/1753-0407.12933. Epub 2019 May 27.
PMID:30983138
Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial.
Beardsall K, Thomson L, Guy C, Iglesias-Platas I, van Weissenbruch MM, Bond S, Allison A, Kim S, Petrou S, Pantaleo B, Hovorka R, Dunger D; REACT collaborative.